EXPERIENCE OF USING TB-TEST TECHNOLOGY (BIOCHIP-IMB, RUSSIA) WITHIN THE DIAGNOSTIC PROCEDURE
https://doi.org/10.21292/2075-1230-2017-95-10-29-35
Abstract
The article analyzes the results of using TB-Test technology (Biochip-IMB, Russia) within the diagnostic procedure for testing clinical specimens with the purpose of tuberculosis diagnostics and drug susceptibility testing in Ural Research Institute of Phthisiopulmonology. The use of this test system is feasible if there are at least 102 cells of tuberculous mycobacteria in 1 ml of the specimen, and there is a high level of multiple drug resistance in the region; and within 2-4 days one test allows detecting mutations associated with resistance to main first and second line TB drugs and performing intraspecific typing of mycobacteria, which is needed for epidemiological monitoring and detection of cases with nosocomial superinfection.
About the Authors
D. V. Vakhrusheva
Ural Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Academic Secretary, Head of Reference Laboratory for Etiological Diagnostics of Tuberculosis and Mycobacteriosis,
50, XXII Parts"ezda St., Yekaterinburg, 620039
N. I. Eremeeva
Ural Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Head of Microbiology and PCR Diagnostics Laboratory,
50, XXII Parts"ezda St., Yekaterinburg, 620039
T. V. Umpeleva
Ural Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
50, XXII Parts"ezda St., Yekaterinburg, 620039
K. V. Belousova
Ural Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
50, XXII Parts"ezda St., Yekaterinburg, 620039
References
1. Bespyatykh Yu.А., Zimenkov D.V., Kulagina E.V.et al. Drug susceptibility testing and genotyping of clinical strains of Mycobacterium tuberculosis using the experimental toolkit of TB-TEST. Pulmonoloiya, 2013, no. 4, pp. 77-81. (In Russ.)
2. Bobrovskaya K.V., Kamaev E.Yu., Kravchenko M.А., Vakhrusheva D.V. Testing drug susceptibility of M.tuberculosis to rifampicin and isoniazid by absolute concentrations and analysis of mutations using biological microchips. Omskiy Nauchny Vestnik, no. 1 (84), 2009, pp. 9-13. (In Russ.)
3. Vakhrusheva D.V., Golubev D.N. Skhema bakteriologicheskogo obsledovaniya patsientov, postupayuschikh v priemno-diagnosticheskoe otdelenie UNIIF. [Bacteriological testing scheme of the patients admitted to the admission diagnostic department of Ural Research Institute of Phthisiopulmonology]. RF Patent no. 82725 as of 16.08.2012.
4. Analysis of genetic determinants of multiple and extensive drug resistance of tuberculous mycobacteria using oligonucleotide microchip. Molekulyarnaya Biologiya, 2014, vol. 48, no. 2, pp. 1-14. (In Russ.)
5. Isakova Zh.T., Sovkhozova N.А., Goncharova Z.K., Аldashev А.А.Comparative analysis of DST by absolute concentrations and biological microchips. Tuberculosis and Lung Diseases, 2011, no. 3, pp. 57-59. (In Russ.)
6. Kravchenko M.А., Eremeeva N.I., Kamaev E.Yu. et al. Skhema «Nabor stranits algoritma etiologicheskoy diagnostiki tuberkuleza i kontrolya khimioterapii». [Scheme on the set of pages for the procedure of etiological diagnostics of tuberculosis and treatment monitoring]. RF Patent no. 89414 as of 16.07.2014.
7. Nosova E.Yu., Krasnova M.А., Galkina K.Yu. Comparative efficiency of molecular test systems of TB-Biochip, Xpert MTB/Rif and Genotype MTBDRplus for rapid detection of mutations accounting for drug resistance of Мycobacterium tuberculosis complex (in specimens collected from the respiratory tract of the patients residing in Moscow Region). Molekulyarnaya Biologiya, 2013, vol. 47, no. 2, pp. 267. (In Russ.)
8. Nosova E.Yu., Khakhalina А.А., Isakova А.I. et al. Simultaneous testing of genetic determinants of extensive drug resistance and genotyping of M. tuberculosis with hybrid biochip analysis. Tuberkulez i Sotsialno-Znachimye Zabolevaniya, 2016, no. 2, pp. 24-33. (In Russ.)
9. Pavlova M.V., Sapozhnikova N.V., Zhuravlev V.Yu. et al. Express diagnostics of multiple drug resistance of mycobacterium tuberculosis based on the TB-Biochip test system. Tuberculosis and Lung Diseases, 2011, vol. 88, no. 5, pp. 93. (In Russ.)
10. Umpeleva T.V., Kravchenko M.А., Eremeeva N.I., Vyazovaya А.А., Narvskaya O.V. Molecular genetic characteristics of Mycobacterium tuberculosis strains, circulating in Ural Region of Russia. Infektsiya and Immunitet, 2013, vol. 3, no. 1, pp. 21-28. (In Russ.)
11. Federalnye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya. [Federal recommendations for diagnostics and treatment of respiratory tuberculosis in children]. Moscow, Tver, Triada Publ., 2014. 56 p.
12. Federal clinical recommendations for diagnosis and treatment of respiratory tuberculosis with multiple and extensive drug resistance. Moscow, Tver, Triada Publ., 2014. 72 p.
13. Federal'nye klinicheskie rekomendatsii po organizatsii i provedeniyu mikrobiologicheskoy i molekulyarno-geneticheskoy diagnostiki tuberkuleza. [Federal clinical recommendations in organisation and implementation of microbiological and molecular-genetic diagnostics of tuberculosis]. Moscow, 2015. 35 p.
14. BakuBa Z., Napiorkowska A., Bielecki J. et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland. Biomed. Res. Intern., 2013, vol. 167954, pp. 5.
15. Bespyatykh J.A., Zimenkov D.V., Shitikov E.A. et al. Spoligotyping of Mycobacterium tuberculosis complex isolates using hydrogel oligonucleotide microarrays. Infection, Genetics and Evolution, 2014, vol. 26, pp. 41-46.
16. Nosova E.Y., Zimenkov D.V., Khakhalina A.A. еt al. A comporation of the Sensititre MycoTB Plate, the Bactec MGIT 960, and microarray-based molecular assay for the detection of drug resistance in clinical Mycobacterium tuberculosis isolates in Moscow, Russia. PLOS ONE|DOI:10.1371/journal.pone.0167093.
17. Plinke C., Rusch-Gerdes S., Niemann S. Significance of mutations in embB Codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy, 2006, vol. 50, no. 5, pp. 1900-1902.
18. Zimenkov D.V., Antonova O.V., Kuz'min A.V. et al. Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays. BMC Infectious Diseases, 2013, no. 13, pp. 240.
19. Zimenkov D.V., Kulagina E.V., Antonova O.V. еt al. Evaluation of a low-density hydrogel microarray technique for Mycobacterial species identification. J. Clinical Microbiology, 2015, vol. 53, no. 4, pp. 1103-1114.
Review
For citations:
Vakhrusheva D.V., Eremeeva N.I., Umpeleva T.V., Belousova K.V. EXPERIENCE OF USING TB-TEST TECHNOLOGY (BIOCHIP-IMB, RUSSIA) WITHIN THE DIAGNOSTIC PROCEDURE. Tuberculosis and Lung Diseases. 2017;95(10):29-35. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-10-29-35
Views:
1553
Email this article 